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Available online 14 May 2016Purpose: To evaluate the relationship between both dynamic and steady-state measures of cerebrovascular reac-
tivity (CVR) and the progression of age-related white matter disease.
Methods: Blood oxygen level-dependent (BOLD) MRI CVR scans were acquired from forty-ﬁve subjects (age
range: 50–90 years, 25 males) with moderate to severe white matter disease, at baseline and one-year follow-
up. To calculate the dynamic (τ) and steady-state (ssCVR) components of the BOLD signal response, the
PETCO2 signal waveform was convolved with an exponential decay function. The τ corresponding to the best
ﬁt between the convolved PETCO2 and BOLD signal deﬁned the speed of response, and the slope of the regression
between the convolved PETCO2 and BOLD signal deﬁned ssCVR. ssCVR and τ were compared between normal-
appearing white matter (NAWM) that remains stable over time and NAWM that progresses to white matter
hyperintensities (WMHs).
Results: In comparison to contralateral NAWM, NAWM that progressed to WMH had signiﬁcantly lower ssCVR
values by mean (SD) 46.5 (7.6)%, and higher τ values by 31.9 (9.6)% (both P b 0.01).
Conclusions: Vascular impairment in regions of NAWM that progresses to WMH consists not only of decreased
magnitude of ssCVR, but also a pathological decrease in the speed of vascular response. These ﬁndings support
the association between cerebrovascular dysregulation and the development of WMH.
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Carbon dioxide1. Introduction
In elderly individuals,magnetic resonance imaging (MRI) of cerebral
white matter frequently shows patchy or conﬂuent hyperintensity on
T2-weighted images, termed “white matter hyperintensities” (WMHs)
if they are of presumed vascular origin (Wardlaw et al., 2013). WMHs
occur predominantly in the periventricular white matter, particularly
around the horns of the lateral ventricles and in the centrum semiovale.
Population-based studies show the prevalence of WMHs on MRI in el-
derly people to be 62–95% (Liao et al., 1997; Launer et al., 2006).l, Joint Department of Medical
Bathurst St., Toronto, ON M5T
lis).
lis wish to be listed as co-senior
en access article under the CC BY-NCGiven this high prevalence in normally functioning elderly individuals,
WMHswere initially considered benign. However, subsequent research
showed that WMHs are associated with disability (Whitman et al.,
2001; Blahak et al., 2009), cognitive decline (Verdelho et al., 2010),
and progression to dementia (Schmidt et al., 2002; Gunning-Dixon
and Raz, 2000). Nevertheless, the detailed pathophysiology of WMH
progression remains poorly understood, and is the subject of this
investigation.
The mechanisms leading to WMHs are complex. Age-related steno-
sis and hypoperfusion of medullary arterioles may cause low grade is-
chemic injury to deep white matter. In addition, impaired vascular
autoregulation may contribute to the progression of WMHs in areas
that are not well capillarized, predisposing white matter to hypoperfu-
sion injury. Uh et al. (2010) found a reduction in both cerebrovascular
reactivity (CVR) and cerebral blood ﬂow (CBF) in regions ofWMH com-
pared to normal-appearingwhitematter (NAWM). They also noted that
areas of WMH were characterized by signiﬁcant blood-brain barrier
leakage and abnormal diffusion MRI metrics.-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Baseline characteristics of subjects. Abbreviations: MoCA = Montreal Cognitive Assess-
ment; WMH=white matter hyperintensities.
Parameter Value (total n= 45)
Demographics
Age, in years, mean (SD) 74 (9.4)
Men, n (%) 25 (56)
Baseline WMH volume, ccs (SD) 32 (25)
MoCA, mean (SD), 6 missing values 25 (4)
Vascular risk factors, n (%)
Ischemic stroke 12 (27)
Transient ischemic attack 6 (13)
Coronary artery disease 7 (16)
Hypertension 23 (51)
Hypercholesterolemia 19 (42)
Diabetes mellitus 3 (7)
Current smoking 3 (7)
Obstructive sleep apnea 5 (11)
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tive stimulus. We have established a quantitative approach to measur-
ing CVR using blood oxygen level-dependent (BOLD) MRI as a
surrogate for blood ﬂow and controlling the end-tidal partial pressures
of carbon dioxide (PETCO2) and oxygen (PETO2) to provide a standard-
ized vasoactive stimulus (Spano et al., 2013). By applying a square
wave change in PETCO2 during BOLD imaging, we are able to parse
CVR into two different metrics: 1) steady-state component of CVR
(ssCVR), which occurs after the vasodilatory response to the CO2 stimu-
lus is complete. Mathematically, it is the asymptote of the exponential
rise in the BOLD signal in response to a rapid (step change) in arterial
PCO2 and 2) Tau (τ), which represents the rate constant of this expo-
nential and is a metric indicating how rapidly a vascular bed can re-
spond to a step change in PCO2. It is of physiological interest as it is an
indicator of vascular compliance (Poublanc et al., 2015).
We measured these metrics in areas of WMH as well as in NAWM
that progress to WMH on follow-up imaging, with particular attention
to the speed of the vascular response. Supporting this approach is a re-
cent study that found that the cerebral deepwhitematter has prolonged
τ and reduced ssCVR compared to grey matter (Poublanc et al., 2015).
We hypothesized that reduced ssCVR and prolonged τ would occur in
WMHs as well as NAWM that progressed to WMH with time, when
compared to NAWM that did not progress to WMH.
2. Methods
2.1. Subject recruitment and assessment
This prospective bi-centric study examined elderly subjects with
moderate to severe WMH at two time points set one year apart (base-
line and follow-up). This study conformed to the standards set by the
latest revision of the Declaration of Helsinki and was approved by the
Research Ethics Board of the University Health Network and Research
Ethics Board of Sunnybrook Health Sciences Centre. Written informed
consent was obtained from all participants. Subjects were recruited
from outpatient neurology clinics at Toronto Western Hospital (TWH)
and Sunnybrook Health Sciences Centre (SHSC). Magnetic resonance
angiography (MRA) or computed tomography angiography (CTA) and
T2-weighted ﬂuid-attenuated inversion recovery (FLAIR) images of all
patients were screened by experienced neuroradiologists (D.J.M. &
D.M.M.). Subjects were enrolled based on the following inclusion
criteria: (1) no recent white matter infarct (patients were excluded if
they had a previous DWI positive white matter infarct within the
3 months preceding study enrolment); (2) no prior cortical infarct
N2 cm or cavitary white matter lesion N2 cm; (3) over the age of 50;
(4) MRI white matter disease burden ≥ Fazekas Grade 2; (5) no hemo-
dynamically signiﬁcant (i.e., N50%) ICA or vertebrobasilar stenosis on
CTA orMRA; (6) no evidence of dissection; (7) no history of pulmonary
or cardio-embolic disease.
Subjects with motion artifacts on BOLD images were excluded.
Forty-ﬁve subjects (age range, 50 to 91 years; 25 males and 20 females)
with moderate to severe WMHs met the inclusion criteria and
were considered in the subsequent analysis (see Table 1 for subject
characteristics).
2.2. Image acquisition
Subjects underwent MRI scans on either a 3-Tesla GE system (Signa
HDx platform, GE Healthcare, Milwaukee, Wis) or a 3-Tesla Philips
Achieva system (Philips Medical Systems, Best, Netherlands) using an
eight-channel phased array head coil. Subjects were asked to refrain
from heavy exercise and drinking alcohol or caffeine on the day of
each scan. The image acquisition parameters were as follows, with
values provided for SHSC/TWH: T1-weighted 3D spoiled gradient echo
sequence [slice thickness = 1.2 mm (SHSC)/1.5 mm (TWH); no
interslice gap; matrix size = 256 × 256; ﬁeld of view = 22 × 22 cm;nominal voxel size = 0.85 × 0.85 × 1.2/0.85 × 0.85 × 1.5 mm;
ﬂip angle = 8 / 20°; TE = 2.3/3 ms; TR = 7.8/9.5 ms] and BOLD
fMRI using a T2*-weighted echoplanar imaging gradient echo
sequence [slice thickness = 3.0/5.0 mm; ﬁeld of view = 24 × 24 cm;
matrix size = 64 × 64; nominal voxel size = 3.75 × 3.75 × 3/
3.75 × 3.75 × 5 mm; ﬂip angle = 85/90°; TE = 30 ms; TR = 2000 ms].
2.3. CVR measurement
CVR is deﬁned as the change in blood ﬂow in response to a vasoac-
tive stimulus. BOLD MRI was used as a surrogate of blood ﬂow
(Poublanc et al., 2015; Sobczyk et al., 2015; Sam et al., 2015), and an
abrupt step increase in the end-tidal partial pressure of carbon dioxide
(PETCO2) was used as the vasoactive stimulus (Han et al., 2011). CVR
was calculated as % change in BOLD/Δ PETCO2, and a color scale ranging
from blue to red was used to identify the magnitude of CVR. Negative
CVR values were represented in shades of blue, and positive CVR values
were represented as shades of yellow, orange, and red.
2.4. Vasodilatory stimulus (gas manipulation, end-tidal pCO2 and pO2
manipulation)
Control of end-tidal partial pressures of carbon dioxide and oxygen
(PETO2) was achieved using an automated gas blender that adjusts the
gas composition and ﬂow to a sequential gas delivery breathing circuit
(RespirActTM, Thornhill Research Inc., Toronto, Canada) as previously
described (Slessarev et al., 2007; Fierstra et al., 2013). The PETCO2 se-
quence used during BOLD measurements was 40 mmHg for 60 s
(normocapnia), followed by an abrupt hypercapnic step change to
PETCO2 of 50 mmHg for 90 s, a return to baseline for 90 s, a second
hypercapnic step change for 120 s, and a return to baseline (Poublanc
et al., 2015). Normoxia (PETO2 ~110 mmHg) was maintained
throughout.
2.5. Generating steady-state CVR and τmaps
PETCO2 was ﬁrst synchronized with the whole brain average BOLD
signal using MATLAB software (Mathworks, Natick, Massachusetts,
USA) to compensate for delays in breath sampling and blood ﬂow tran-
sit time from the pulmonary to the cerebral circulation. BOLD responses
were parsed into steady-state (ssCVR) and dynamic (τ) components
using a convolved PETCO2 stimulus instead of the measured PETCO2, as
previously described (Poublanc et al., 2015). Brieﬂy, the BOLD response
was modeled as the PETCO2 convolved with an exponential decay func-
tion [exp(−t/τ)] representing the hemodynamic response, where t is
time and τ is the time constant of the vascular response. τwas allowed
to vary from 2 to 100 s in 2 s increments, giving rise to 50 convolved sig-
nals. The τ of the convolved PETCO2with the highest Pearson correlation
798 K. Sam et al. / NeuroImage: Clinical 11 (2016) 796–801coefﬁcient with the BOLD response was taken as ameasure of the speed
of response for that particular voxel. ssCVR was calculated as the slope
of the regression between the BOLD response and the convolved
PETCO2 waveform that provided the highest Pearson correlation
(Poublanc et al., 2015). ssCVR values were expressed as percentMR sig-
nal change per mmHg of PETCO2, whereas τ is measured in seconds.
Representative maps of ssCVR, and τ are shown in Fig. 1.2.6. Generating ROIs of WMH and NAWM
Segmentation of baseline WMH was performed using the Lesion
Explorer processing pipeline (Ramirez et al., 2011, 2014). To identify
novel WMH on follow-up, the baseline WMH segmentation was over-
laid onto follow-up FLAIR, proton density (PD), and T2-weighted im-
ages. Evidence of novel WMH on all three image series was required
for a lesion to be classiﬁed as newly developed WMH. Such lesions
were then manually segmented using AFNI (Cox, 1996). T1-weighted
anatomical images were segmented into cerebrospinal ﬂuid, grey mat-
ter, and white matter using SPM8 (Wellcome Department of Imaging
Neuroscience, Institute of Neurology, University College, London, UK).
A diamond shaped structuring element was used to erode the white
matter ROI in ﬁve iterations at the resolution of the T1-weighted
image to prevent partial volume effects. The WMH ROI was then
subtracted from the eroded WM ROI to give rise to an ROI containing
only NAWM.Fig. 1. CVRmetrics used to characterize futureWMHs. (A) T1-weighted images from a subjectw
subject showing reduced CVR in areas of WMHs. (C) Tau map demonstrating slower vascular r
baseline scan. Two color scales are used to represent regions with positive ssCVR (red to green)
up scan. (F)WMHs identiﬁedon the baseline scan are highlighted in yellow. (G)WMHs identiﬁe
up are highlighted in red. CVR values are in units of % BOLD/mmHg.2.7. Accounting for the confounding factor of spatial location
One important confound in our study is the spatial error associated
with each metric due to spatial location; e.g. periventricular CVR may
be less than that in white matter near the cortical surface. To account
for possible spatial error of the MRI metrics, T1-weighted images were
transformed into Montreal Neurological Institute space using SPM8.
This transformation matrix was then applied to other MRI metrics,
transforming these maps to a standard space but retaining their native
structure. Finally, a second ROI of the NAWM was generated that is
contralateral and spatially homologous to WMH (Fig. 2).
2.8. Statistical analyses
MRI metrics were compared for the following four ROIs:
1) grey matter;
2) pre-existing WMH;
3) all NAWM; and
4) the subset of NAWM voxels that progressed to WMH on the follow-
up scan.
All statistical comparisons were based on a within-subject repeated
measures design, which accounted for between-subject differences.
Comparison of ssCVR between ROIs was performed using Friedman's
test with Dunn's correction for multiple comparisons. Comparison of τ
between ROIs was performed using repeated measures one-wayith diffuse periventricular and deepWMHs. (B) Steady-state CVR (ssCVR)map in the same
esponses to carbon dioxide in regions of WMHs. (D) FLAIR images showing WMHs on the
and negative ssCVR (light blue to purple). (E) FLAIR images showingWMHs on the follow-
donbaseline are highlighted in yellowwhereas newhyperintensities identiﬁedon follow-
Fig. 2. ROIs used in the comparison of NAWM and hyperintensities considering the confounding spatial factor. (A) FLAIR images from a subject with diffuse periventricular and deep
WMHs. (B) WMHs are highlighted in yellow and overlaid on a FLAIR image. (C) WMHs without the underlying FLAIR map. (D) Image C is left-right ﬂipped about the y-axis in MNI
coordinates while retaining native structure. (E) Image D is subtracted from Image C, giving rise to NAWM that is contralateral to hyperintensities. (F) Image E is left-right ﬂipped
about the y-axis to give rise to the original WMH mask; however, only voxels with contralateral NAWM remain. (G) The ﬁnal NAWMmask (image E) and WMHmask (image F) used
in the characterization of CVR metrics are overlaid on FLAIR images.
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the matched-pairs independent variable. Bonferroni corrections for
multiple comparisons were made and signiﬁcance was assumed as
P b 0.05 / (6 comparisons) = 0.008. Mauchly's test was used to detect
signiﬁcant departures from sphericity and degrees of freedomwere ad-
justed using the Greenhouse–Geisser or Huynh-Feldt correction as ap-
propriate. When controlling for differences due to spatial location,
comparisons were also made betweenWMHs and contralateral homol-
ogous NAWM using either Wilcoxon matched-pairs signed ranks test
(for CVR and ssCVR measurements) or two-tailed paired t-tests (for τ
measurements). Statistical signiﬁcance was assessed with α= 0.001.3. Results
Forty-ﬁve subjects (age range: 50–90 years, 25 males) with moder-
ate to severeWMHsparticipated in this study. Reasons for referral to the
memory or stroke prevention clinic included chronic imbalance and
headaches, memory impairment, cognitive decline, transient episodes
of paresthesia, or syncopal episodes. These subjects had a mean (SD)
WMH volume of 26.7 (23.5) mLs per subject at baseline (mean age:
73.1 years), an average WMH volume of 30.0 (25.1) mLs per subject
on one-year follow-up, and a WMH progression rate of 0.66 (0.60)
mLs/year.
The mean (SD) for each cerebrovascular metric in each group is
summarized in Table 2. ssCVR and τ for grey matter were signiﬁcantly
different (P b 0.01) from those in all other groups (NAWM, pre-existing
WMH, and NAWM that progressed to WMH). All metrics for NAWM
were signiﬁcantly different from those in all other groups. NAWM that
progressed to WMH on follow-up had lower ssCVR [0.086 (0.076) vs.
0.172 (0.056) %BOLD/mmHg] and longer τ values [46.02 (15.86) vs.
35.62 (9.30) seconds] compared to NAWM that did not progress to
WMHs (P b 0.01).
The time constant τ was longer in pre-existing WMH compared to
NAWM that did not progress to WMHs [50.25 (11.52) vs. 35.62 (9.30)
seconds, P b 0.001]. Using spatially corrected regions, this difference
was reduced but remained signiﬁcant [36.95 (7.59) seconds for WMH
vs. 34.72 (8.01) seconds for NAWM, P b 0.001] (Table 3). Differences
in CVRmetrics between pre-existingWMH and NAWM that progressed
to WMH compared to NAWM that did not progress to WMHs are illus-
trated in Fig. 3.Table 2
Comparison of CVR metrics in regions of NAWM that progressed to WMH against other tissue
with Dunn's correction for multiple comparison while comparisons involving τ were made usi
Grey matter All NAWM
ssCVR [% BOLD/mmHg] 0.32
(0.07)
0.17
(0.06)⁎
τ [s] 23.50
(7.47)
35.62
(9.30)⁎
⁎ Denotes signiﬁcance vs. grey matter ( P b 0.01).
+ Denotes signiﬁcance vs. all NAWM (P b 0.01). No signiﬁcant differences were observed be4. Discussion
This is the ﬁrst report of prolonged vascular response times in
NAWM that subsequently progresses to WMH. Neither ssCVR, which
represents the time-independent magnitude of the BOLD response to
a square-wave vasodilatory stimulus, nor τ, which measures the speed
of the vasodilatory response, have beenmeasured previously in the con-
text of age-related whitematter disease. Our ﬁndings therefore support
the hypothesis that chronic hypoperfusion plays a role in the develop-
ment of WMHs. Unlike the richly collateralized cortex, white matter is
vulnerable to the development of WMHs because it is perfused by
long penetrating medullary end-arteries with poor collateralization.
This vascular architecture provides little protection from ischemia dur-
ingperiods of generalized vasodilatation,where bloodﬂow is redirected
to areas of preserved vasodilatory capacity (Roman, 1987; Mandell et
al., 2008; Sobczyk et al., 2014). The CVR ﬁndings are consistent with a
prior report by Uh et al. (2010) who found that CVR in WMHs was ap-
proximately half of that in NAWM.
The reduced CVR in NAWM that progressed toWMHwe foundmay
provide a resolution of the conﬂicting evidence supporting hypoperfu-
sion as amechanism for the pathogenesis ofWMHs.While several stud-
ies have demonstrated reduced CBF inWMHs (Ishii et al., 1986; Fazekas
et al., 1988), it is nevertheless unclear whether hypoperfusion is a caus-
ative factor forWMHsor a secondary response to the reducedmetabolic
activity of leukoaraiotic tissue. Our results demonstrate that reductions
in ssCVR inNAWMregions precede the development ofWMHs, suggest-
ing that hemodynamic impairment may be an etiological factor.
Previous studies have looked at vascular response times. The
cerebral pial vessels in cats respond to changes in pH rapidly, within ap-
proximately 10s (Greensburg and Reivich, 1977). Previous studies in
humans using inhalation of carbogen found that 5min was required to
reach peak ﬂow values as measured by a N2O washout method
(Shapiro et al., 1965). However, this is also the approximate time course
for change in arterial PCO2 after the administration of carbogen (Fisher,
2016) so a faster peak response time could not have been detected. In
contrast, our study measured the vascular dynamics in the WM with a
change in PETCO2 within one to two breaths allowing the detection of
vascular response times as brief as 10s (i.e. 2 breaths).
Our ﬁnding of slowed vascular responses in NAWM that progresses
to WMH is consistent with observations of the penumbra of large in-
farcts (Englund, 2002), where the hypoperfusion seen in the penumbratypes. Values are given as mean (SD). ssCVR comparisons were made using Friedman test
ng repeated measures one-way ANOVA with Bonferroni correction.
Pre-existing WMH Baseline NAWM that progressed to WMH
0.11
(0.06)⁎+
0.09
(0.08)⁎+
50.25
(11.52)⁎+
46.02
(15.86)⁎+
tween pre-existing WMH and NAWM that progressed to WMHs.
Table 3
Comparison of CVRmetrics in pre-existing white matter hyperintensities and contralater-
al homologous white matter regions. Values are given as mean (SD).
Pre-existing WMHs Contralateral NAWM
ssCVR [% BOLD/mmHg] 0.11 (0.06) 0.18 (0.06)⁎
τ [s] 36.95 (7.59) 34.72 (8.01)⁎
⁎ Denotes signiﬁcance against pre-existing WMHs (P b 0.001) using Wilcoxon matched-
pairs signed ranks test for CVR and ssCVR and two-tailed paired t-test for τ.
800 K. Sam et al. / NeuroImage: Clinical 11 (2016) 796–801of large infarcts also displays prolonged time-dependent metrics
measured with dynamic susceptibility contrast perfusion imaging
(Campbell et al., 2012; Srinivasan et al., 2006). These includemean tran-
sit time, time-to-peak of the tissue-concentration curve, and time-to-
peak of the deconvolved tissue residue function. Prolonged τ has also
been reported in patients with unilateral large artery steno-occlusive
disease (Poublanc et al., 2015). Together these ﬁndings are consistent
with the notion that dysregulation of cerebral blood ﬂow control and
chronic low-grade ischemia play a causative role in WMH progression.
Some previous studies have suggested that differences between
WMH and NAWM are due to regional variability in metabolic demand.
Indeed, blood ﬂow reductions in WMHs found in a study using 18 F
ﬂuoromethane positron emission tomography (Herholz et al., 1990)
were thought to result from the lower metabolic demands of the cortex
rendered electrophysiologically isolated by subjacent zones of
degenerated white matter tissue. According to this notion, hypoperfu-
sionmay not be involved in the pathophysiology ofWMHs. Also, hemo-
dynamically signiﬁcant extracranial carotid stenosis has been shown
not to correlate with the presence of ipsilateral WMHs (Fazekas et al.,
1988) although WMH progression has been shown to correlate with
signiﬁcant carotid stenosis that advanced to complete occlusion
(Ylikoski et al., 1993). In spite of these ﬁndings, we have shown a reduc-
tion in steady-state CVR, and prolonged τ in WMHs compared to the
contralateral homologous NAWM, suggesting that abnormal vascular
responses are an etiologic mechanism of WMH progression.
A strength and unique feature of our study is the ability to accurately
control PETCO2 throughout the experiment. The magnitude of the stim-
ulus may determine the distribution of blood ﬂow during steal physiol-
ogy (Sobczyk et al., 2014). All subjects had an abrupt 10 mmHg change
in PETCO2 (within 1-2 breaths) from an average baseline of 40 mmHg,
providing a consistent stimulus between subjects. Consistency in stim-
ulus magnitude reduces the uncertainty of test-to-test CVR variability.
The time proﬁle of the stimulus, which in our study was 10 s, allowed
us to measure a range of response times 10 s and longer. Vascular
response times faster than the changes in the arterial PCO2 (which are
seldom known) cannot be measured.Fig. 3.Comparison of cerebrovascularmetrics in regions of pre-existing and futureWMHs.
All values are given as % change from contralateral NAWM and assessed on baseline MRI
scans. Values for future WMHs are made in the NAWM on the baseline scan (before the
progression into overt WMH). ssCVR are signiﬁcantly lower and τ is signiﬁcantly higher
in pre-existing and future WMHs compared to NAWM. * denotes signiﬁcance compared
to NAWM (P b 0.01). Bars indicate minimum and maximum, boxes indicate the
interquartile range (25th to 75th percentile) and the line within each box indicates the
median.4.1. Limitations
We assumed that the BOLD signal was a surrogate measure of CBF.
Although the BOLD signal has a complex dependency upon CBF, hemat-
ocrit, cerebral blood volume, and cerebral metabolic rate for oxygen
(Ogawa et al., 1993), CBF measured with arterial spin labeling has dem-
onstrated a linear relationship with the BOLD signal in the PETCO2 range
of 40 to 50 mmHg (Tancredi and Hoge, 2013). Mandell et al. (2008)
have also previously shown a highly correlated BOLD signal response
to hypercapnia compared with CBF measurements obtained with ASL
in patients with large artery steno-occlusive disease.
Our measurements also assume that changes in the arterial partial
pressure of CO2 do not inﬂuence CMRO2. This assumption is supported
by experiments showing that increases in CBF through vasodilation pro-
duce very little or no increases in CMRO2 (Sokoloff, 1981).
5. Conclusion
In summary, these experiments show that both the magnitude and
the speed of the vascular response to a CO2 challenge are reduced in
NAWM that progresses toWMH. This is the ﬁrst report to show that ab-
normal dynamic cerebrovascular response precedes the development of
WMH.
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